Burkitt lymphoma high-risk features: HIV+ AND CD4 <100 OR ECOG ≥3 OR LDH >3× ULN OR CNS i...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-BURKITT-HIGH-RISK |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-BURKITT |
| Sources | SRC-ESMO-BURKITT-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Burkitt lymphoma high-risk features: HIV+ AND CD4 <100 OR ECOG ≥3 OR LDH >3× ULN OR CNS involvement OR bulky abdominal disease — selects more intensive CODOX-M/IVAC over DA-EPOCH-R |
|---|---|
| Clinical direction | intensify |
| Category | high-risk-biology |
| Shifts algorithm | ALGO-BURKITT-1L |
Trigger Logic
{
"any_of": [
{
"finding": "burkitt_high_risk",
"value": true
},
{
"finding": "cns_involvement",
"value": true
},
{
"finding": "ldh_above_3x_uln",
"value": true
},
{
"finding": "leukemic_phase",
"value": true
},
{
"finding": "bulky_abdominal",
"value": true
}
],
"type": "composite_clinical"
}
Notes
CALGB 10002 / CALGB 50202 evidence that DA-EPOCH-R is sufficient for most adult Burkitt INCLUDING HIV-associated, but high-risk features push to CODOX-M/IVAC (Magrath) or hyper-CVAD/MA. CNS involvement is mandatory CODOX-M/IVAC (HD-MTX dose-intense regimen).
Used By
Algorithms
ALGO-BURKITT-1L- ALGO-BURKITT-1L
Indications
IND-BURKITT-1L-CODOXM-IVAC- IND-BURKITT-1L-CODOXM-IVACIND-BURKITT-1L-DAEPOCHR- IND-BURKITT-1L-DAEPOCHRIND-BURKITT-1L-HYPERCVAD-R- IND-BURKITT-1L-HYPERCVAD-RIND-BURKITT-2L-RICE-ASCT- IND-BURKITT-2L-RICE-ASCTIND-EMERG-TLS-PROPHYLAXIS-RASBURICASE- IND-EMERG-TLS-PROPHYLAXIS-RASBURICASE